» Articles » PMID: 36972571

Eosinophilic Esophagitis Beyond Eosinophils - an Emerging Phenomenon Overlapping with Eosinophilic Esophagitis: Collegium Internationale Allergologicum (CIA) Update 2023

Overview
Date 2023 Mar 27
PMID 36972571
Authors
Affiliations
Soon will be listed here.
Abstract

Having long been considered the mainstay in eosinophilic esophagitis (EoE) diagnosis and pathogenesis, the role of eosinophils has been questioned and might be less important than previously thought. It is well known now that EoE is a Th2-mediated disease with many more disease features than eosinophilic infiltration. With more knowledge on EoE, less pronounced phenotypes or nuances of the disease have become apparent. In fact, EoE might be only the tip of the iceberg (and the most extreme phenotype) with several variant forms, at least three, lying on a disease spectrum. Although a common (food induced) pathogenesis has yet to be confirmed, gastroenterologists and allergologists should be aware of these new phenomena in order to further characterize these patients. In the following review, we discuss the pathogenesis of EoE, particularly those mechanisms beyond eosinophilic infiltration of the esophageal mucosa, non-eosinophilic inflammatory cell populations, the new disease entity EoE-like disease, variant forms of EoE, and the recently coined term mast cell esophagitis.

Citing Articles

Eosinophilic oesophagitis in adults: from symptoms to therapeutic options.

Rossi C, Lenti M, Santacroce G, Merli S, Vanoli A, Di Sabatino A Intern Emerg Med. 2024; .

PMID: 39729261 DOI: 10.1007/s11739-024-03846-7.


Novel transcriptomic panel identifies histologically active eosinophilic oesophagitis.

Gueguen E, Morsy Y, Mamie C, Schoepfer A, Saner C, Biedermann L Gut. 2024; 73(7):1076-1086.

PMID: 38670631 PMC: 11187384. DOI: 10.1136/gutjnl-2023-331743.

References
1.
Ocampo A, Genta R, Dellon E . Mast Cell Esophagitis: A Novel Entity in Patients with Unexplained Esophageal Symptoms. Dysphagia. 2023; 39(3):360-368. PMC: 10879451. DOI: 10.1007/s00455-023-10616-8. View

2.
Whelan K, Godwin B, Wilkins B, Elci O, Benitez A, DeMarshall M . Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019; 18(7):1475-1482.e1. PMC: 7058491. DOI: 10.1016/j.cgh.2019.08.055. View

3.
Youngblood B, Brock E, Leung J, Falahati R, Bochner B, Rasmussen H . Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight. 2019; 4(19). PMC: 6795394. DOI: 10.1172/jci.insight.126219. View

4.
Hruz P, Straumann A, Bussmann C, Heer P, Simon H, Zwahlen M . Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011; 128(6):1349-1350.e5. DOI: 10.1016/j.jaci.2011.09.013. View

5.
Blatman K, Gonsalves N, Hirano I, Bryce P . Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy. J Allergy Clin Immunol. 2011; 127(5):1307-8.e3. PMC: 3085639. DOI: 10.1016/j.jaci.2010.12.1118. View